Multi-targeted tyrosine kinase inhibitors as third-line regimen in advanced non-small cell lung cancer: a network meta-analysis.
Zhang Z, Zhao Y, Lu F, Hou X, Ma Y, Luo F, Zeng K, Zhao S, Zhang Y, Zhou T, Yang Y, Fang W, Huang Y, Zhang L, Zhao H.
Zhang Z, et al. Among authors: zhao h, zhao y, zhao s.
Ann Transl Med. 2019 Sep;7(18):452. doi: 10.21037/atm.2019.08.51.
Ann Transl Med. 2019.
PMID: 31700888
Free PMC article.